Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy

201587 citationsJournal Article

Authors

Luís F. Quintana · Universitat de Barcelona

Miquel Blasco · Universitat de Barcelona

Miguel Seras

Nuria Pérez · Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Abstract

This study is the first to demonstrate pretransplantation circulating anti-PLA2R antibodies in a cohort of renal transplant recipients who prospectively developed recurrent disease. Currently, anti-PLA2R levels measured by ELISA may be a rational tool to establish the risk of MN recurrence in renal allograft recipients.

Topics & Keywords

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Renal and Vascular Pathologies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplantation

Volume 99, Issue 8, pp. 1709-1714

DOI: 10.1097/tp.0000000000000630

Field-Weighted Citation Impact: 5.73